锥体外系副作用评定量表。 - Suppr

Suppr

超能文献

A rating scale for extrapyramidal side effects.

作者信息

Simpson G M, Angus J W

出版信息

Acta Psychiatr Scand Suppl. 1970;212:11-9. doi: 10.1111/j.1600-0447.1970.tb02066.x.

DOI:10.1111/j.1600-0447.1970.tb02066.x

PMID:4917967

Abstract

摘要

相似文献

A rating scale for extrapyramidal side effects.

Acta Psychiatr Scand Suppl. 1970;212:11-9. doi: 10.1111/j.1600-0447.1970.tb02066.x.

A controlled trial of combined medications on behavioral and extrapyramidal effects.

Acta Psychiatr Scand Suppl. 1970;212:20-7. doi: 10.1111/j.1600-0447.1970.tb02067.x.

[On the problem of the therapeutical axis symptom of neuroleptic medicaments].

Psychiatr Neurol Med Psychol (Leipz). 1968 Aug;20(8):286-95.

[A chronic extrapyramidal syndrome as a complication of neuroleptic therapy].

Zh Nevropatol Psikhiatr Im S S Korsakova. 1969;69(12):1862-8.

A comparison of haloperidol and Trifluoperazine. (A double-blind, controlled study on chronic schizophrenic outpatients).

Dis Nerv Syst. 1967 Mar;28(3):181-6.

Drug-induced extrapyramidal disorders.

Res Publ Assoc Res Nerv Ment Dis. 1972;50:448-71.

[Complex persisting dyskinesia, secondary to neuroleptic therapy].

Rev Neurol (Paris). 1969 Mar;120(3):215-9.

[Extrapyramidal symptoms during the use of neuroleptics].

Nervenarzt. 1967 Apr;38(4):151-5.

[On the problem of persistent extrapyramidal hyperkinesia following prolonged use of neuroleptics].

Nervenarzt. 1967 Apr;38(4):170-4.

[Use of haloperidol in the treatment of extrapyramidal compulsive movement].

Nervenarzt. 1970 Nov;41(11):567-9.

引用本文的文献

The associations of suicidal ideation with psychopathology and inflammatory cytokines in patients with chronic schizophrenia.

BMC Psychiatry. 2025 Aug 18;25(1):793. doi: 10.1186/s12888-025-07263-8.

Safety and Tolerability of Brexpiprazole in Participants with Agitation Associated with Dementia due to Alzheimer's Disease: Pooled Analysis of Three Randomized Trials and an Extension Trial.

CNS Drugs. 2025 Jul 19. doi: 10.1007/s40263-025-01200-9.

Quantification of motor abnormalities with instrumental tasks among adolescents with first-episode schizophrenia and depressive disorders.

Sci Rep. 2025 Jul 1;15(1):22151. doi: 10.1038/s41598-025-06590-w.

Safety and Tolerability of Brexpiprazole in Adolescents With Schizophrenia: A Long-Term, Open-Label Study.

JAACAP Open. 2024 May 27;3(2):313-322. doi: 10.1016/j.jaacop.2024.04.005. eCollection 2025 Jun.

Description of schizophrenia treatment outcomes in Saudi Arabia: A preliminary pilot investigation.

J Int Med Res. 2025 Apr;53(4):3000605251332443. doi: 10.1177/03000605251332443. Epub 2025 Apr 22.

Characterization of the white matter networks in schizophrenia patients with metabolic syndrome undergoing risperidone or clozapine treatment.

Front Neurosci. 2025 Apr 2;19:1579810. doi: 10.3389/fnins.2025.1579810. eCollection 2025.

Switching antipsychotics versus continued current treatment in people with non-responsive schizophrenia.

Cochrane Database Syst Rev. 2025 Apr 11;4(4):CD011885. doi: 10.1002/14651858.CD011885.pub2.

Does KarXT (xanomeline-trospium) represent a novel approach to schizophrenia management? A GRADE-assessed systematic review and meta-analysis of randomized controlled clinical trials.

BMC Psychiatry. 2025 Mar 31;25(1):309. doi: 10.1186/s12888-025-06696-5.

Randomized Double Blind Inpatient Study of a Gluten-Free Diet in Persons with Schizophrenia.

medRxiv. 2025 Feb 25:2025.02.24.25322813. doi: 10.1101/2025.02.24.25322813.

Network analysis of clinical features in patients with treatment-resistant schizophrenia.

Front Psychiatry. 2025 Feb 6;16:1537418. doi: 10.3389/fpsyt.2025.1537418. eCollection 2025.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

A rating scale for extrapyramidal side effects.

作者信息

Simpson G M, Angus J W

出版信息

Acta Psychiatr Scand Suppl. 1970;212:11-9. doi: 10.1111/j.1600-0447.1970.tb02066.x.

DOI:10.1111/j.1600-0447.1970.tb02066.x

PMID:4917967

Abstract

摘要

相似文献

A rating scale for extrapyramidal side effects.

Acta Psychiatr Scand Suppl. 1970;212:11-9. doi: 10.1111/j.1600-0447.1970.tb02066.x.

A controlled trial of combined medications on behavioral and extrapyramidal effects.

Acta Psychiatr Scand Suppl. 1970;212:20-7. doi: 10.1111/j.1600-0447.1970.tb02067.x.

[On the problem of the therapeutical axis symptom of neuroleptic medicaments].

Psychiatr Neurol Med Psychol (Leipz). 1968 Aug;20(8):286-95.

[A chronic extrapyramidal syndrome as a complication of neuroleptic therapy].

Zh Nevropatol Psikhiatr Im S S Korsakova. 1969;69(12):1862-8.

A comparison of haloperidol and Trifluoperazine. (A double-blind, controlled study on chronic schizophrenic outpatients).

Dis Nerv Syst. 1967 Mar;28(3):181-6.

Drug-induced extrapyramidal disorders.

Res Publ Assoc Res Nerv Ment Dis. 1972;50:448-71.

[Complex persisting dyskinesia, secondary to neuroleptic therapy].

Rev Neurol (Paris). 1969 Mar;120(3):215-9.

[Extrapyramidal symptoms during the use of neuroleptics].

Nervenarzt. 1967 Apr;38(4):151-5.

[On the problem of persistent extrapyramidal hyperkinesia following prolonged use of neuroleptics].

Nervenarzt. 1967 Apr;38(4):170-4.

[Use of haloperidol in the treatment of extrapyramidal compulsive movement].

Nervenarzt. 1970 Nov;41(11):567-9.

引用本文的文献

The associations of suicidal ideation with psychopathology and inflammatory cytokines in patients with chronic schizophrenia.

BMC Psychiatry. 2025 Aug 18;25(1):793. doi: 10.1186/s12888-025-07263-8.

Safety and Tolerability of Brexpiprazole in Participants with Agitation Associated with Dementia due to Alzheimer's Disease: Pooled Analysis of Three Randomized Trials and an Extension Trial.

CNS Drugs. 2025 Jul 19. doi: 10.1007/s40263-025-01200-9.

Quantification of motor abnormalities with instrumental tasks among adolescents with first-episode schizophrenia and depressive disorders.

Sci Rep. 2025 Jul 1;15(1):22151. doi: 10.1038/s41598-025-06590-w.

Safety and Tolerability of Brexpiprazole in Adolescents With Schizophrenia: A Long-Term, Open-Label Study.

JAACAP Open. 2024 May 27;3(2):313-322. doi: 10.1016/j.jaacop.2024.04.005. eCollection 2025 Jun.

Description of schizophrenia treatment outcomes in Saudi Arabia: A preliminary pilot investigation.

J Int Med Res. 2025 Apr;53(4):3000605251332443. doi: 10.1177/03000605251332443. Epub 2025 Apr 22.

Characterization of the white matter networks in schizophrenia patients with metabolic syndrome undergoing risperidone or clozapine treatment.

Front Neurosci. 2025 Apr 2;19:1579810. doi: 10.3389/fnins.2025.1579810. eCollection 2025.

Switching antipsychotics versus continued current treatment in people with non-responsive schizophrenia.

Cochrane Database Syst Rev. 2025 Apr 11;4(4):CD011885. doi: 10.1002/14651858.CD011885.pub2.

Does KarXT (xanomeline-trospium) represent a novel approach to schizophrenia management? A GRADE-assessed systematic review and meta-analysis of randomized controlled clinical trials.

BMC Psychiatry. 2025 Mar 31;25(1):309. doi: 10.1186/s12888-025-06696-5.

Randomized Double Blind Inpatient Study of a Gluten-Free Diet in Persons with Schizophrenia.

medRxiv. 2025 Feb 25:2025.02.24.25322813. doi: 10.1101/2025.02.24.25322813.

Network analysis of clinical features in patients with treatment-resistant schizophrenia.

Front Psychiatry. 2025 Feb 6;16:1537418. doi: 10.3389/fpsyt.2025.1537418. eCollection 2025.